Risk Profiles and Treatment Patterns Among Men Diagnosed as Having Prostate Cancer and a Prostate-Specific Antigen Level Below 4.0 ng/m

July 26, 2010 | Journal Article

Lowering the biopsy threshold for prostate cancer from a PSA of 4.0 to 2.5 would increase the risk of overdiagnosis and overtreatment, according to this first large-scale study of current treatment patterns in the U.S. population.